Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2015; 09(03): 364-372
DOI: 10.4103/1305-7456.163238
Original Article
Dental Investigation Society

Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas

Ugrappa Sridevi
1   Department of Oral Medicine and Radiology, Faculty of Dentistry, AIMST Dental Institute, AIMST University, Kedah, Malaysia
,
Ajay Jain
2   Department of Prosthodontics, Faculty of Dentistry, AIMST Dental Institute, AIMST University, Kedah, Malaysia
,
Velpula Nagalaxmi
3   Department of Oral Medicine and Radiology, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India
,
Ugrappa Vijay Kumar
4   Private Practitioner, Hyderabad, Telangana, India
,
Stuti Goyal
5   Department of Oral Medicine & Radiology, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India
› Author Affiliations
Further Information

Publication History

Publication Date:
04 September 2019 (online)

   Permissions and Reprints

ABSTRACT

Objective: The aim of the present study was to assess the expression of E-cad in oral precancerous lesions and conditions and oral carcinomas in comparison with normal mucosa. Materials and Methods: Total of 50 samples were selected for the study and were categorized into five groups and 10 samples in each group as Group I-oral leukoplakia (OL), Group II-oral lichen planus (OLP), Group III-oral submucous fibrosis (OSMF), Group IV-oral squamous cell carcinoma (OSCC) and Group V-normal oral mucosa (NOM) as control group. All the samples were assessed for the expression of E-cad by immunohistochemical study. Results: Upon assessing the expression of E-cad in OL, OSMF, OLP and OSCC, as majority of the samples with OSCC (90%), OL (80%), OLP (70%) and OSMF (60%) showed mild to moderate expression of E-cad staining, which was suggestive of reduction in dysplastic cells on comparison to NOM cells. This difference in expression and variation of E-cad upon comparison with normal mucosa was statistically significant (P < 0.001). Conclusion: There is significant (P < 0.001) variation of expression of E-cad with the histopathological dysplasia of the oral precancerous lesions and conditions, and the tumor differentiation of the oral cancers. However, there was no correlation of the degree of loss of expression of E-cad with the degree of dysplasia or the tumor differentiation of oral cancers. We conclude with our study that, there is a variation in the expression of E-cad but its value as a prognostic marker is questionable.

Key words:

E-cadherin - immunohistochemistry - oral carcinoma - oral precancerous lesions
 

  • REFERENCES

  • 1 Das RK, Pal M, Barui A, Paul RR, Chakraborty C, Ray AK. et al. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression. J Clin Pathol 2010; 63: 894-9
    CrossrefPubMedGoogle Scholar
  • 2 Narayan S. Oral cancer in India: An epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 1990; 69: 325-30
    CrossrefPubMedGoogle Scholar
  • 3 Greenberg MS, Glick M. Burket's Oral Medicine. 11th ed.. Hamilton: BC Decker Inc.; 2008
    Google Scholar
  • 4 Jankowski JA, Bruton R, Shepherd N, Sanders SA. Cadherin and catenin biology represents a global mechanism for epithelial cancer mechanism. J Clin Pathol Mol Pathol 1997; 50: 289-90
    CrossrefPubMedGoogle Scholar
  • 5 Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000; 87: 992-1005
    CrossrefPubMedGoogle Scholar
  • 6 Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjänen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174: 101-9
    CrossrefPubMedGoogle Scholar
  • 7 Rajendran R. Oral leukoplakia. J Oral Maxillofac Pathol 2004; 8: 58-68
    Google Scholar
  • 8 van der Waal I. Potentially malignant disorders of the oral and oro-pharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009; 45: 317-23
    CrossrefPubMedGoogle Scholar
  • 9 Kiran KumarK, Saraswathi TR, Ranganathan K, Uma DeviM, Elizabeth J. Oral submucous fibrosis: A clinico-histopathological study in Chennai. Indian J Dent Res 2007; 18: 106-11
    CrossrefPubMedGoogle Scholar
  • 10 Andreasen JO. Oral lichen planus.1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968; 25: 31-42
    CrossrefPubMedGoogle Scholar
  • 11 Neppelberg E, Loro LL, Oijordsbakken G, Johannessen AC. Altered CD40 and E-cadherin expression – Putative role in oral lichen planus. J Oral Pathol Med 2007; 36: 153-60
    CrossrefPubMedGoogle Scholar
  • 12 Robbins SL, Kumar V, Cotran RS. Basic Pathology. 7th ed.. Philadelphia, U.S: Elsevier Publications; 2003: p. 165-211
    Google Scholar
  • 13 Simionescu C, Margaritescu C, Surpateanu M, Mogoanta L, Zavoi R, Ciurea R. et al. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma. Rom J Morphol Embryol 2008; 49: 189-93
    PubMedGoogle Scholar
  • 14 Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope 2001; 111: 1373-8
    CrossrefPubMedGoogle Scholar
  • 15 Downer CS, Speight PM. E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur J Cancer B Oral Oncol 1993; 29B: 303-5
    PubMedGoogle Scholar
  • 16 Yogesh T, Narayan T, Shreedhar B, Shashidara R. Leekymohanty. The expression of E-cadherin and cathepsin-D in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma: A comparative analysis between immunohistochemistry and routine histopathology. J Oral Maxillofac Pathol 2011; 15: 288-94
    CrossrefPubMedGoogle Scholar
  • 17 Rajendran R, Shivapathasundaram B. editors. Shafer's Textbook of Oral Pathology. 5th ed.. New Delhi, India: Reed Elsevier India; 2006
    Google Scholar
  • 18 Raina C, Raizada RM, Chaturvedi VN, Harinath BC, Puttewar MP, Kennedy AK. Clinical profile and serum beta-carotene levels in oral submucous fibrosis. Indian J Otolaryngol Head Neck Surg 2005; 57: 191-5
    Google Scholar
  • 19 Yuwanati MB, Tupkari JV, Avadhani A. Expression of E-cadherin in oral epithelial dysplasia and oral squamous cell carcinoma: An in vivo study. J Clin Exp Invest 2011; 2: 347-53
    Google Scholar
  • 20 Chaw SY, Majeed AA, Dalley AJ, Chan A, Stein S, Farah CS. Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – In oral squamous cell carcinogenesis and transformation. Oral Oncol 2012; 48: 997-1006
    CrossrefPubMedGoogle Scholar
  • 21 Kaur J, Sawhney M, DattaGupta S, Shukla NK, Srivastava A, Walfish PG. et al. Clinical significance of altered expression of ß-catenin and E-cadherin in oral dysplasia and cancer: Potential link with ALCAM expression. PLoS One 2013; 8: e67361
    CrossrefPubMedGoogle Scholar
  • 22 Ganapathy KS, Gurudath S, Balikai B, Ballal S, Sujatha D. Role of iron deficiency in oral submucous fibrosis: An initiating or accelerating factor. J Indian Acad Oral Med Radiol 2011; 23: 25-8
    CrossrefGoogle Scholar
  • 23 Neppelberg E, Johannessen AC. DNA content and Cyclooxygenase-2 as risk markers of cancer development in oral lichen planus. Eur Arch Otorhinolaryngol 2007; 264: 1223-30
    CrossrefPubMedGoogle Scholar
  • 24 Ebrahimi M, Boldrup L, Wahlin YB, Coates PJ, Nylander K. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus. Oral Oncol 2008; 44: 634-8
    CrossrefPubMedGoogle Scholar
  • 25 Shinohara M, Hiraki A, Ikebe T, Nakamura S, Kurahara S, Shirasuna K. et al. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: Correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 1998; 184: 369-81
    CrossrefPubMedGoogle Scholar
  • 26 Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006; 42: 190-200
    PubMedGoogle Scholar
  • 27 Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35: 589-94
    CrossrefPubMedGoogle Scholar